InfuSystem Holdings, Inc. (INFU) Stock
InfuSystem stock price chart
INFU stock quote & key statistics
InfuSystem annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $143.4M | $6.6M | $0.50 |
| FY2024 | $134.9M | $2.3M | $0.18 |
| FY2023 | $125.8M | $872,000 | $0.09 |
| FY2022 | $109.9M | $18,000 | $0.01 |
| FY2021 | $102.4M | $1.4M | $0.08 |
Fiscal year ending December 31. Source: company filings via EODHD.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., headquartered in Rochester Hills, Michigan, is a leading provider of infusion pumps and related products and services across the United States and Canada. Operating through its subsidiaries, the company serves two primary segments: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). Its offerings include electronic ambulatory infusion pumps and disposable supply kits, essential for oncology, infusion, and hospital outpatient chemotherapy clinics treating various cancers like colorectal cancer, as well as managing pain and other medical conditions.
In addition to sales, InfuSystem Holdings, Inc. offers rental and leasing options for both new and pre-owned pole-mounted and ambulatory infusion pumps, along with other durable medical equipment. The company also provides biomedical recertification, maintenance, and repair services, supporting oncology practices and other healthcare settings such as home care providers, skilled nursing facilities, pain centers, and hospitals. This comprehensive service model includes local and field-based customer support and operates specialized pump service and repair centers.
Established in 2005, InfuSystem Holdings, Inc. has solidified its position as a trusted partner in the healthcare industry, leveraging its extensive network and expertise to meet the evolving needs of healthcare providers. Its strategic focus on delivering high-quality products and services underscores its commitment to enhancing patient care and operational efficiency across diverse clinical settings.
Located in Michigan, a hub for healthcare innovation, InfuSystem Holdings, Inc. benefits from proximity to key markets and a skilled workforce. With a dedication to innovation and customer satisfaction, the company continues to expand its footprint while maintaining a steadfast commitment to excellence in medical equipment services.
InfuSystem stock FAQ
What is the InfuSystem stock ticker symbol?
InfuSystem Holdings, Inc. trades on the NYSE American under the ticker symbol INFU.
What sector and industry is InfuSystem in?
InfuSystem Holdings, Inc. is classified in the Healthcare sector, Medical Devices industry.
How many employees does InfuSystem have?
InfuSystem Holdings, Inc. has about 461 full-time employees.
What were InfuSystem's revenue and earnings last fiscal year?
InfuSystem reported revenue of $143.4M and net income of $6.6M in fiscal 2025, with earnings per share of $0.50. Revenue grew 6.4% from the prior year.
Is InfuSystem in the Russell 2000?
Yes. InfuSystem Holdings, Inc. (INFU) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did InfuSystem go public?
InfuSystem stock began trading on December 27, 2007.
Russell 2000 Medical Devices stocks
All Russell 2000 →- AORTArtivion
- ATECAlphatec
- AXGNAxoGen
- BFLYButterfly Network
- CNMDCONMED
- ENOVEnovis
- ESTAEstablishment Labs
- GKOSGlaukos
- HAEHaemonetics
- IARTIntegra LifeSciences
- INSPInspire Medical Systems
- IRTCiRhythm
- ITGRInteger
- LIVNLivaNova
- NEOGNeogen
- NVCRNovoCure
- PRCTPROCEPT BioRobotics
- QDELQuidelOrtho
- SIBNSI-BONE
- TMDXTransMedics
- TNDMTandem Diabetes Care
- TXG10x Genomics
- UFPTUFP Technologies
- VREXVarex Imaging